Skip to main content
    S

    Seres Therapeutics Inc (MCRB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.41
    +0.00 (+0.00%)

    Market Cap: $14.27M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Seres Therapeutics Inc (MCRB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Seres Therapeutics (MCRB) has a latest price of $1.41 on Nov 17, 2026, 95.3% below its 52-week high of $29.98. Its price fell 91.5% over the past 12 months. The month-end price fell 99.2% over the 10 years through Oct 2026, a compound annual decline of 38.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $566.20 in Sep 2020 and its lowest $1.77 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MCRB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MCRB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 69.9%, and over 6 months it fell 81.0%. The month-end price fell 94.2% over the 3 years through Oct 2026, a compound annual decline of 61.3%.

    PeriodChange
    1 month-41.7%
    3 months-69.9%
    6 months-81.0%
    12 months-91.5%
    12 months, with dividends-91.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-94.2%-61.3%
    5 years-98.5%-57.1%
    10 years-99.2%-38.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 610.1%, and its weakest was 2023, when it fell 75.0%.

    YearCloseChange
    2026 through Oct 2026$1.77-88.1%
    2025$14.88-10.5%
    2024$16.62-40.6%
    2023$28.00-75.0%
    2022$112.00-32.8%
    2021$166.60-66.0%
    2020$490.00+610.1%
    2019$69.00-23.7%
    2018$90.40-55.4%
    2017$202.80+2.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 49.5% below its 50-day average of $2.79 and 77.6% below its 200-day average of $6.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.41
    52-week high$29.98-95.3%
    52-week low$1.30+8.5%
    50-day average$2.79-49.5%
    200-day average$6.29-77.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 95.5%.

    MeasureValue
    1-year beta1.43
    Largest fall, 1 year-95.1%
    Largest fall, 3 years-95.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MCRB

    What is MCRB's 1-year price change?

    Seres Therapeutics's price fell 91.5% over the past 12 months. With dividends included, the 12-month total return was -91.5%.

    What is MCRB's 5-year price change?

    Seres Therapeutics's month-end price fell 98.5% over the 5 years through Oct 2026, a compound annual decline of 57.1%. These figures leave out dividends.

    What is MCRB's 52-week high and low?

    Seres Therapeutics's 52-week high is $29.98 and its 52-week low is $1.30. Its latest price of $1.41 on Nov 17, 2026 is 95.3% below the high.

    What is MCRB's beta?

    Seres Therapeutics's 1-year beta against the S&P 500 is 1.43, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 95.1%.

    Is the MCRB chart free?

    Yes. Advanced Charting for MCRB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.